Northwest Biotherapeutics (NWBO) – FDA
-
Northwest Biotherapeutics (NWBO) had 'significant, negative disclosure in newly filed 10K' - Adam Feurstein
-
Northwest Biotherapeutics (NWBO) Highlights Updated Interim Data from Phase 3 Trial of DCVax-L for Glioblastoma
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to NWBO Stock Lookup